Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders??? Equity (Deficit)

v3.22.4
Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Millions
Total
Private Placement
Cumulative Effect, Period of Adoption, Adjustment
Class A Common Stock
Ordinary Shares
A Ordinary Shares
Ordinary Shares
B Ordinary Shares
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Private Placement
Common Stock
Class B Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Receivable from Employees for purchase of Common Stock
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance (in shares) at Jun. 30, 2019         1,483,795 5,353,970                    
Beginning balance at Jun. 30, 2019 $ (587.7)         $ 0.1       $ 9.3   $ (2.5) $ (610.6)   $ 13.4 $ 2.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Distribution to noncontrolling interests (0.4)                             (0.4)
Issuance of shares of common stock to Mirion Sellers and recognition of noncontrolling interests in Mirion Business Combination 0.0                              
Share-based compensation expense 0.2                 0.2            
Receivable from Employees (0.2)                     (0.2)        
Net loss (119.1)                       (119.1)      
Other comprehensive loss (9.3)                           (9.3)  
Ending balance (in shares) at Jun. 30, 2020         1,483,795 5,353,970                    
Ending balance at Jun. 30, 2020 (716.5)         $ 0.1       9.5   (2.7) (729.7)   4.1 2.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of shares of common stock to Mirion Sellers and recognition of noncontrolling interests in Mirion Business Combination 0.0                              
Receivable from Employees 0.3                     0.3        
Net loss (158.4)                       (158.3)     (0.1)
Other comprehensive loss 35.1                           35.1  
Ending balance (in shares) at Jun. 30, 2021         1,483,795 5,353,970                    
Ending balance at Jun. 30, 2021 (839.5)         $ 0.1       9.5   (2.4) (888.0)   39.2 2.1
Ending balance (Accounting Standards Update 2016-02) at Jun. 30, 2021     $ (2.9)                     $ (2.9)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of shares of common stock to Mirion Sellers and recognition of noncontrolling interests in Mirion Business Combination 0.0                              
Share-based compensation expense 9.3                 9.3            
Receivable from Employees 1.6                     1.6        
Net loss (105.7)                       (105.7)     0.0
Other comprehensive loss (6.9)                           (6.9)  
Ending balance (in shares) at Oct. 19, 2021         1,483,795 5,353,970                    
Ending balance at Oct. 19, 2021 (944.1)         $ 0.1       18.8   $ (0.8) (996.6)   32.3 2.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Reclassification of temporary equity shares previously subject to redemption (in shares)       14,628,610                        
Ending balance (in shares) at Oct. 20, 2021                 18,750,000              
Ending balance at Oct. 20, 2021 (109.4)                       (109.4)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of shares of class B shares of common stock to class A (in shares)             (18,750,000)   18,750,000              
Reclassification of temporary equity shares previously subject to redemption (in shares)             60,371,390                  
Reclassification of temporary equity shares previously subject to redemption 603.7                 603.7            
Issuance of Class A Common Shares to PIPE Investors, net of offering costs (in shares)               90,000,000                
Issuance of shares of Class A common stock to PIPE Investors, net of offering costs   $ 886.7                 $ 886.7          
Issuance of Common Shares to Mirion Sellers and recognition of noncontrolling interests in Mirion Business Combination (in shares)             30,401,902   8,560,540              
Issuance of shares of common stock to Mirion Sellers and recognition of noncontrolling interests in Mirion Business Combination 420.7                 329.1           91.6
Equity contribution from Mirion Sellers 18.7                 18.7            
Forgiveness of working capital note from Sponsor 2.0                 2.0            
Share-based compensation expense 5.3                 5.3            
Net loss (23.0)                       (22.2)     (0.8)
Other comprehensive loss (20.7)                           (20.7)  
Ending balance (in shares) at Dec. 31, 2021             199,523,292   8,560,540              
Ending balance at Dec. 31, 2021 1,784.0           $ 0.0   $ 0.0 1,845.5     (131.6)   (20.7) 90.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Warrant redemptions (in shares)             100                  
Conversion of shares of class B shares of common stock to class A (in shares)             520,000   (520,000)              
Conversion of shares of class B common stock to class A common stock 0.0                 5.1           (5.1)
Issuance of shares of common stock to Mirion Sellers and recognition of noncontrolling interests in Mirion Business Combination 0.0                              
Stock issued for vested restricted stock units (in shares)             220,396                  
Stock compensation to directors in lieu of cash compensation (in shares)             35,046                  
Stock compensation to directors in lieu of cash compensation 0.4                 0.4            
Purchase accounting adjustments to fair value of noncontrolling interests (1.9)                             (1.9)
Share-based compensation expense 31.4                 31.4            
Net loss (288.4)                              
Other comprehensive loss (58.3)                           (55.0) (3.3)
Ending balance (in shares) at Dec. 31, 2022             200,298,834   8,040,540              
Ending balance at Dec. 31, 2022 $ 1,467.2           $ 0.0   $ 0.0 $ 1,882.4     $ (408.5)   $ (75.7) $ 69.0